Table 2.
Top CpG sites from adjusted associations of gestational PFAS concentrations with repeated measures of DNA methylation in the HOME Study (at delivery and at 12 years of age) and Project Viva (at delivery and at 7 years of age).
| CpG | Chr | Position | CpG location | Gene | Gene region | FANTOM5 enhancers | ENCODE DNAse hypersensitivity sites | Discovery cohort [ (-value)] | FDR -value | Replication cohort [ (-value)] | Replicateda |
|---|---|---|---|---|---|---|---|---|---|---|---|
| PFOA | |||||||||||
| cg25869005 | 14 | 95048198 | Open sea | SERPINA5 | 5′UTR | — | chr14:95047965-95048250 | 0.101 () | 0.003 | NA | — |
| cg03707973 | 12 | 54826237 | Open sea | LOC102724050 | Body | — | chr12:54826045-54826655 | () | 0.008 | NA | — |
| cg04042784 | 7 | 42884749 | Open sea | — | — | — | — | 0.078 () | 0.008 | NA | — |
| cg09309282 | 2 | 236523347 | Open sea | AGAP1 | Body | — | chr2:236523145-236523410 | () | 0.015 | NA | — |
| cg22971191 | 13 | 103719706 | Open sea | SLC10A2 | Promoter | — | — | 0.121 () | 0.023 | (0.435) | |
| cg01787798 | 1 | 175474437 | Open sea | TNR | 5′UTR | — | chr1:175474340-175474655 | () | 0.023 | (0.001) | |
| cg04977784 | 5 | 53972541 | Open sea | LOC102467080 | Body | chr5:53972314-53972314 | chr5:53972220-53972635 | 0.060 () | 0.043 | NA | — |
| cg14212748 | 12 | 53343703 | Shore | KRT18 | Body | — | chr12:53343445-53343855 | () | 0.043 | (0.492) | — |
| cg05195288 | 3 | 65582834 | Open sea | MAGI1 | Body | — | — | 0.073 () | 0.043 | NA | — |
| cg21821684 | 15 | 47686828 | Open sea | — | — | — | chr15:47686685-47686890 | 0.104 () | 0.043 | (0.379) | — |
| cg16415457 | 3 | 23713441 | Open sea | — | — | — | chr3:23713340-23713815 | () | 0.048 | (0.007) | |
| cg03760072 | 3 | 133502685 | Island | SRPRB | Promoter | — | chr3:133502565-133503275 | () | 0.048 | NA | — |
| PFOS | |||||||||||
| cg16381104 | 6 | 99578913 | Open sea | — | — | — | chr6:99578800-99579035 | 0.060 () | 0.011 | NA | — |
| cg21421331 | 10 | 100618466 | Open sea | HPSE2 | Body | — | chr10:100618360-100618610 | 0.076 () | 0.033 | NA | — |
| PFHxS | |||||||||||
| cg02794779 | 13 | 100150711 | Island | — | — | — | — | () | 0.007 | (0.106) | — |
| cg11331322 | 3 | 42530661 | Open sea | VIPR1 | Promoter | — | — | 0.086 () | 0.018 | NA | — |
| cg00983482 | 10 | 130083707 | Open sea | — | — | — | chr10:130082925-130083755 | 0.082 () | 0.022 | (0.440) | — |
| cg26477711 | 12 | 39518309 | Open sea | — | — | — | — | 0.088 () | 0.030 | NA | — |
| cg24735489 | 6 | 31088352 | Open sea | CDSN;PSORS1C1 | Promoter;5′UTR | — | chr6:31088120-31088430 | () | 0.042 | 0.019 (0.227) | — |
| cg03639671 | 4 | 145430689 | Open sea | — | — | — | — | 0.085 () | 0.042 | (0.087) | — |
| cg00457165 | 6 | 31088366 | Open sea | CDSN;PSORS1C1 | Promoter;5′UTR | — | chr6:31088120-31088430 | () | 0.043 | NA | — |
| cg00647458 | 4 | 139760831 | Open sea | — | — | — | — | 0.063 () | 0.046 | NA | — |
| PFNA | |||||||||||
| cg25601695 | 16 | 55690178 | Island | SLC6A2 | 5′UTR;Promoter | — | chr16:55689225-55691015 | () | 0.002 | NA | — |
| cg04509825 | 14 | 62162178 | Island | HIF1A | 1stExon;5′UTR | — | chr14:62161865-62162315 | () | 0.008 | 0.002 (0.807) | — |
| cg01713535 | 14 | 57046409 | Shore | C14orf101 | Promoter | — | chr14:57046105-57047510 | () | 0.008 | 0.019 (0.525) | — |
| cg11506907 | 11 | 118972568 | Shore | DPAGT1 | 5′UTR;1stExon | — | chr11:118972040-118973615 | () | 0.008 | 0.005 (0.672) | — |
| cg12967001 | 18 | 5544089 | Island | EPB41L3 | Promoter | — | chr18:5543880-5544455 | () | 0.008 | (0.681) | — |
| cg05792003 | 1 | 95582492 | Shore | TMEM56 | Promoter | — | chr1:95582305-95582570 | () | 0.009 | 0.002 (0.874) | — |
| cg24620436 | 7 | 4918906 | Shelf | RADIL | 5′UTR | — | chr7:4918205-4919455 | 0.209 () | 0.009 | 0.118 (0.055) | — |
| cg09861318 | 3 | 149530987 | Island | RNF13 | 1stExon;5′UTR | — | chr3:149530185-149531075 | () | 0.009 | 0.011 (0.544) | — |
| cg26975787 | 12 | 2613778 | Open sea | CACNA1C | Body | — | — | () | 0.029 | (0.010) | |
| cg24822529 | 5 | 134582880 | Open sea | — | — | — | chr5:134582625-134582950 | () | 0.033 | (0.005) | |
| cg19497517 | 8 | 145028257 | Island | PLEC1 | Body;TSS200 | — | chr8:145028185-145028535 | 0.194 () | 0.035 | 0.073 (0.027) | |
| cg02842197 | 17 | 5389625 | Island | DERL2;MIS12 | TSS200;TSS1500 | — | chr17:5389485-5389890 | 0.136 () | 0.042 | 0.048 (0.026) | |
Note: All models were adjusted for child age and sex, annual household income (median income of each category), maternal race/ethnicity (non-Hispanic white, other) and smoking during pregnancy (yes, no), and cell type composition. CpG sites were annotated to a promoter region if they were assigned toTSS200 or TSS1500. Data were complete for all variables. PFAS concentrations below the LOD were replaced with the LOD divided by the square root of 2. We analyzed longitudinal associations between PFAS concentrations and repeated DNA methylation measures using a generalized estimating equations (GEE) approach with an identity link function, a working independence correlation matrix and normal errors. can be interpreted as the differences in the logits of DNA methylation proportions across the two visits per 2-fold increase in gestational PFAS concentrations. Statistically significant CpG sites were defined as having an FDR (PFOA, PFOS, and PFHxS) or (PFNA). —, not annotated to any known gene; 5′UTR, between the TSS and the ATG start site; 1stExon, the first exon of the gene; Chr, chromosome; CpG, cytosine–guanine dinucleotide; Body, between the ATG and stop codon; FDR, false discovery rate; HOME, Health Outcomes and Measures of the Environment; LOD, limit of detection; NA, not available in 450K microarray; PFAS, perfluoroalkyl substances; PFHxS, perfluorohexane sulfonate; PFNA, perfluorononanoate; PFOA, perfluorooctanoate; PFOS, perfluorooctane sulfonate; TSS, transcription start site; TSS200, 200 bases from TSS; TSS1500, 1,500 bases from TSS, UTR, untranslated region.
CpGs with a and the same direction of associations observed in the HOME Study were considered as successful replications.